Antibiotics Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Antibiotics Market to 2027 - Global Analysis and Forecasts By Drug Class ( Sulfonamides, Aminoglycosides, Carbapenem, Macrolides, Fluoroquinolones, Penicillin, Cephalosporin, Others ); Action Mechanism ( Mycolic Acid Inhibitors, RNA Synthesis Inhibitors, Mycolic Acid Inhibitors, DNA Synthesis Inhibitors, Protein Synthesis Inhibitors, Cell Wall Synthesis Inhibitors

Report Code: TIPRE00003406 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION
Antibiotics are powerful medicines that are used to fight against bacterial infections. Antibiotics are also known as antibacterials which include a range of powerful drugs and are used to treat diseases caused by bacteria. These are specifically used to treat infections caused by bacteria such as, Staph., Strep., or E. coli. and either kill the bacteria (bactericidal) or keep it from reproducing and growing (bacteriostatic). The antibiotics do not work against any viral infection. Some common infections treated with antibiotics are, conjunctivitis, skin or soft tissue infection, upper respiratory tract infection, bronchitis, streptococcal pharyngitis (strep throat) and among others.

MARKET DYNAMICS
The antibiotics market is anticipated to grow in the forecast period owing to driving factors such as, rise in the cases of infectious diseases and major investments in R&D activities by pharmaceutical companies. Moreover, increasing efforts undertaken by major companies for the development of advanced products will also support market growth and increased consumption of antibiotics in low & middle-income countries is anticipated to offer more growth opportunities for the players operating in the antibiotics market.

MARKET SCOPE
The "Global Antibiotics Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of antibiotics market with detailed market segmentation by drug class, action mechanism and geography. The global antibiotics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading antibiotics market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global antibiotics market is segmented on the basis of drug class and action mechanism. Based on drug class, the market is segmented as, sulfonamides, aminoglycosides, carbapenem, macrolides, fluoroquinolones, penicillin, cephalosporin and others. On the basis of action mechanism, the global antibiotics market is segmented as, mycolic acid inhibitors, RNA synthesis inhibitors, DNA synthesis inhibitors, protein synthesis inhibitors and cell wall synthesis inhibitors.


REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global antibiotics market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The antibiotics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting antibiotics market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the antibiotics market in these regions.

MARKET PLAYERS
The reports cover key developments in the antibiotics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from antibiotics market are anticipated to lucrative growth opportunities in the future with the rising demand for antibiotics market in the global market. Below mentioned is the list of few companies engaged in the antibiotics market.

The report also includes the profiles of key antibiotics market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

• Abbott

• Pfizer, Inc.
• Janssen Pharmaceuticals (Johnson and Johnson Services, Inc.)
• Sanofi
• GlaxoSmithKline plc.
• Bayer AG
• Novartis AG
• Eli Lilly and Company
• Bristol-Myers Squibb Company
• Astellas Pharma, Inc.

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Antibiotics Market - By Drug Class
1.3.2 Antibiotics Market - By Action Mechanism
1.3.3 Antibiotics Market - By Region
1.3.3.1 By Country

2. KEY TAKEWAYS

3. RESEARCH METHODOLOGY

4. ANTIBIOTICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. ANTIBIOTICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. ANTIBIOTICS MARKET - GLOBAL MARKET ANALYSIS
6.1. ANTIBIOTICS - GLOBAL MARKET OVERVIEW
6.2. ANTIBIOTICS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. ANTIBIOTICS MARKET - REVENUE AND FORECASTS TO 2027 - DRUG CLASS
7.1. OVERVIEW
7.2. DRUG CLASS MARKET FORECASTS AND ANALYSIS
7.3. SULFONAMIDES
7.3.1. Overview
7.3.2. Sulfonamides Market Forecast and Analysis
7.4. AMINOGLYCOSIDES
7.4.1. Overview
7.4.2. Aminoglycosides Market Forecast and Analysis
7.5. CARBAPENEM
7.5.1. Overview
7.5.2. Carbapenem Market Forecast and Analysis
7.6. MACROLIDES
7.6.1. Overview
7.6.2. Macrolides Market Forecast and Analysis
7.7. FLUOROQUINOLONES
7.7.1. Overview
7.7.2. Fluoroquinolones Market Forecast and Analysis
7.8. PENICILLIN
7.8.1. Overview
7.8.2. Penicillin Market Forecast and Analysis
7.9. CEPHALOSPORIN
7.9.1. Overview
7.9.2. Cephalosporin Market Forecast and Analysis
7.10. OTHERS
7.10.1. Overview
7.10.2. Others Market Forecast and Analysis

8. ANTIBIOTICS MARKET - REVENUE AND FORECASTS TO 2027 - ACTION MECHANISM
8.1. OVERVIEW
8.2. ACTION MECHANISM MARKET FORECASTS AND ANALYSIS
8.3. MYCOLIC ACID INHIBITORS
8.3.1. Overview
8.3.2. Mycolic Acid Inhibitors Market Forecast and Analysis
8.4. RNA SYNTHESIS INHIBITORS
8.4.1. Overview
8.4.2. RNA Synthesis Inhibitors Market Forecast and Analysis
8.5. MYCOLIC ACID INHIBITORS
8.5.1. Overview
8.5.2. Mycolic Acid Inhibitors Market Forecast and Analysis
8.6. DNA SYNTHESIS INHIBITORS
8.6.1. Overview
8.6.2. DNA Synthesis Inhibitors Market Forecast and Analysis
8.7. PROTEIN SYNTHESIS INHIBITORS
8.7.1. Overview
8.7.2. Protein Synthesis Inhibitors Market Forecast and Analysis
8.8. CELL WALL SYNTHESIS INHIBITORS
8.8.1. Overview
8.8.2. Cell Wall Synthesis Inhibitors Market Forecast and Analysis

9. ANTIBIOTICS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Antibiotics Market Overview
9.1.2 North America Antibiotics Market Forecasts and Analysis
9.1.3 North America Antibiotics Market Forecasts and Analysis - By Drug Class
9.1.4 North America Antibiotics Market Forecasts and Analysis - By Action Mechanism
9.1.5 North America Antibiotics Market Forecasts and Analysis - By Countries
9.1.5.1 United States Antibiotics Market
9.1.5.1.1 United States Antibiotics Market by Drug Class
9.1.5.1.2 United States Antibiotics Market by Action Mechanism
9.1.5.2 Canada Antibiotics Market
9.1.5.2.1 Canada Antibiotics Market by Drug Class
9.1.5.2.2 Canada Antibiotics Market by Action Mechanism
9.1.5.3 Mexico Antibiotics Market
9.1.5.3.1 Mexico Antibiotics Market by Drug Class
9.1.5.3.2 Mexico Antibiotics Market by Action Mechanism
9.2. EUROPE
9.2.1 Europe Antibiotics Market Overview
9.2.2 Europe Antibiotics Market Forecasts and Analysis
9.2.3 Europe Antibiotics Market Forecasts and Analysis - By Drug Class
9.2.4 Europe Antibiotics Market Forecasts and Analysis - By Action Mechanism
9.2.5 Europe Antibiotics Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Antibiotics Market
9.2.5.1.1 Germany Antibiotics Market by Drug Class
9.2.5.1.2 Germany Antibiotics Market by Action Mechanism
9.2.5.2 France Antibiotics Market
9.2.5.2.1 France Antibiotics Market by Drug Class
9.2.5.2.2 France Antibiotics Market by Action Mechanism
9.2.5.3 Italy Antibiotics Market
9.2.5.3.1 Italy Antibiotics Market by Drug Class
9.2.5.3.2 Italy Antibiotics Market by Action Mechanism
9.2.5.4 Spain Antibiotics Market
9.2.5.4.1 Spain Antibiotics Market by Drug Class
9.2.5.4.2 Spain Antibiotics Market by Action Mechanism
9.2.5.5 United Kingdom Antibiotics Market
9.2.5.5.1 United Kingdom Antibiotics Market by Drug Class
9.2.5.5.2 United Kingdom Antibiotics Market by Action Mechanism
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Antibiotics Market Overview
9.3.2 Asia-Pacific Antibiotics Market Forecasts and Analysis
9.3.3 Asia-Pacific Antibiotics Market Forecasts and Analysis - By Drug Class
9.3.4 Asia-Pacific Antibiotics Market Forecasts and Analysis - By Action Mechanism
9.3.5 Asia-Pacific Antibiotics Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Antibiotics Market
9.3.5.1.1 Australia Antibiotics Market by Drug Class
9.3.5.1.2 Australia Antibiotics Market by Action Mechanism
9.3.5.2 China Antibiotics Market
9.3.5.2.1 China Antibiotics Market by Drug Class
9.3.5.2.2 China Antibiotics Market by Action Mechanism
9.3.5.3 India Antibiotics Market
9.3.5.3.1 India Antibiotics Market by Drug Class
9.3.5.3.2 India Antibiotics Market by Action Mechanism
9.3.5.4 Japan Antibiotics Market
9.3.5.4.1 Japan Antibiotics Market by Drug Class
9.3.5.4.2 Japan Antibiotics Market by Action Mechanism
9.3.5.5 South Korea Antibiotics Market
9.3.5.5.1 South Korea Antibiotics Market by Drug Class
9.3.5.5.2 South Korea Antibiotics Market by Action Mechanism
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Antibiotics Market Overview
9.4.2 Middle East and Africa Antibiotics Market Forecasts and Analysis
9.4.3 Middle East and Africa Antibiotics Market Forecasts and Analysis - By Drug Class
9.4.4 Middle East and Africa Antibiotics Market Forecasts and Analysis - By Action Mechanism
9.4.5 Middle East and Africa Antibiotics Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Antibiotics Market
9.4.5.1.1 South Africa Antibiotics Market by Drug Class
9.4.5.1.2 South Africa Antibiotics Market by Action Mechanism
9.4.5.2 Saudi Arabia Antibiotics Market
9.4.5.2.1 Saudi Arabia Antibiotics Market by Drug Class
9.4.5.2.2 Saudi Arabia Antibiotics Market by Action Mechanism
9.4.5.3 U.A.E Antibiotics Market
9.4.5.3.1 U.A.E Antibiotics Market by Drug Class
9.4.5.3.2 U.A.E Antibiotics Market by Action Mechanism
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Antibiotics Market Overview
9.5.2 South and Central America Antibiotics Market Forecasts and Analysis
9.5.3 South and Central America Antibiotics Market Forecasts and Analysis - By Drug Class
9.5.4 South and Central America Antibiotics Market Forecasts and Analysis - By Action Mechanism
9.5.5 South and Central America Antibiotics Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Antibiotics Market
9.5.5.1.1 Brazil Antibiotics Market by Drug Class
9.5.5.1.2 Brazil Antibiotics Market by Action Mechanism
9.5.5.2 Argentina Antibiotics Market
9.5.5.2.1 Argentina Antibiotics Market by Drug Class
9.5.5.2.2 Argentina Antibiotics Market by Action Mechanism

10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

11. ANTIBIOTICS MARKET, KEY COMPANY PROFILES
11.1. ABBOTT
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. PFIZER, INC.
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. JANSSEN PHARMACEUTICALS (T JOHNSON AND JOHNSON SERVICES, INC.)
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. SANOFI
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. GLAXOSMITHKLINE PLC.
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. BAYER AG
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. NOVARTIS AG
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. ELI LILLY AND COMPANY
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. BRISTOL-MYERS SQUIBB COMPANY
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. ASTELLAS PHARMA, INC.
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments

12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. Abbott
2. Pfizer, Inc.
3. Janssen Pharmaceuticals (t Johnson & Johnson Services, Inc.)
4. Sanofi
5. GlaxoSmithKline plc.
6. Bayer AG
7. Novartis AG
8. Eli Lilly and Company
9. Bristol-Myers Squibb Company
10. Astellas Pharma, Inc.
Select License Type
USD $3000
USD $4550
USD $6550
USD $8550

Free

20%

customization on Pre-Booking
Pre Book